Skip to content
naulon
Get started

No retraction, correction or concern found when last checked on Oct 18, 2026.

The mitochondrial permeability transition pore: a mystery solved?

Paolo Bernardi

Frontiers in Physiology · 2013 · Review

doi:10.3389/fphys.2013.00095

Abstract

The permeability transition (PT) denotes an increase of the mitochondrial inner membrane permeability to solutes with molecular masses up to about 1500 Da. It is presumed to be mediated by opening of a channel, the permeability transition pore (PTP), whose molecular nature remains a mystery. Here I briefly review the history of the PTP, discuss existing models, and present our new results indicating that reconstituted dimers of the FOF1 ATP synthase form a channel with properties identical to those of the mitochondrial megachannel (MMC), the electrophysiological equivalent of the PTP. Open questions remain, but there is now promise that the PTP can be studied by genetic methods to solve the large number of outstanding problems.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 18, 2026. Paragraph numbers are ours, so an answer can point at one.

The mitochondrial permeability transition

The permeability transition (PT) defines an increase of mitochondrial inner membrane permeability to ions and solutes with molecular masses up to about 1500 Da leading to matrix swelling. The occurrence of swelling in isolated mitochondria, its strict dependence on matrix Ca2+, stimulation by Pi and fatty acids, and inhibition by Mg2+ and adenine nucleotides has been recognized very early (Raaflaub,,; Brenner-Holzach and Raaflaub,; Hunter and Ford,; Tapley,; Lehninger,; Lehninger and Remmert,; Wojtczak and Lehninger,; Zborowski and Wojtczak,; Azzi and Azzone,; Azzone and Azzi,; Chappell and Crofts,; Crofts and Chappell, ); and its detrimental effects on energy conservation have been described before the emergence of chemiosmotic concepts (Mitchell,, ). As a result, the PT has initially been considered an in vitro artifact of questionable pathophysiological relevance, although a few Authors did recognize its potential importance in pathophysiology (Rasola and Bernardi, ).

Pfeiffer and Coworkers suggested that the permeabilizing effect of Ca2+ had a physiological role in steroidogenesis. These Authors showed that Ca2+ induces a “transformation” of adrenal cortex mitochondria allowing diffusion of extramitochondrial pyridine nucleotides through the otherwise impermeable inner membrane, and that NADPH entering in this way supports the 11-β hydroxylation of deoxycorticosterone (Pfeiffer and Tchen,,; Pfeiffer et al., ). These findings match those of Vinogradov et al., who demonstrated the Ca2+-dependent release of matrix pyridine nucleotides in liver mitochondria (Vinogradov et al., ). The term “permeability transition” was introduced by Haworth and Hunter, who thoroughly characterized its basic features in heart mitochondria. These Authors provided the key insight that the PT was due to reversible opening of a proteinaceous pore in the inner mitochondrial membrane, the permeability transition pore (PTP), whose physiological role remained undefined (Hunter et al.,; Hunter and Haworth,,; Haworth and Hunter, ).

Studies on the PT were not too popular at this time, a possible consequence of the general acceptance of the chemiosmotic hypothesis which had just been fully recognized with the award of the Nobel Prize to Peter Mitchell in 1978. As noted earlier (Bernardi, ) studies of mitochondrial ion transport were indeed carried out in the same laboratories involved in clarifying the mechanisms of energy conservation, and they tended to become tests of the predictions of the chemiosmotic theory. In retrospect it is not too surprising that the existence of a large pore in the inner membrane appeared to contradict the basic tenets of chemiosmosis. As a result, and with very few exceptions (see e.g., Beatrice et al.,; Coelho and Vercesi,; Bernardi and Pietrobon,; Lê-Quôc and Lê-Quôc,,; Siliprandi et al.,; Vercesi,; Riley and Pfeiffer,; Al Nasser and Crompton,; Sokolove and Shinaberry, ) research in this area did not enjoy much popularity.

The discovery that in mammalian mitochondria the PT can be inhibited by submicromolar concentrations of cyclosporin (Cs) A (Fournier et al.,; Crompton et al.,; Broekemeier et al.,; Davidson and Halestrap, ) changed the field substantially. CsA inhibits the PTP after binding to matrix cyclophilin (CyP)D, a peptidyl-prolyl cis-trans isomerase (PPIase) whose enzymatic activity is blocked by CsA (Fischer et al.,; Takahashi et al., ) in the same range of concentrations inhibiting the pore (Connern and Halestrap,,; Nicolli et al.,; Woodfield et al., ). A second fundamental finding was the demonstration that mitochondria possess ion channels that can be studied by electrophysiology (Sorgato et al., ). This seminal study was soon followed by the demonstration that the inner mitochondrial membrane is endowed with a high-conductance (≈1–1.3 nS) channel, the “mitochondrial megachannel” (MMC) (Kinnally et al.,; Petronilli et al., ). The MMC is inhibited by CsA (Szabó and Zoratti, ) and possesses all the key regulatory features of the PTP (Bernardi et al.,; Szabó et al., ) leaving little doubt that the PTP and the MMC are two aspects of the same molecular entity (Szabó and Zoratti, ). Electrophysiology has greatly contributed to our understanding of the MMC–PTP, and to acceptance of the pore theory of the PT (Zoratti et al., ).

Involvement of the PT in cell death was hypothesized 25 years ago (Crompton and Costi, ). Early support was obtained in hepatocytes subjected to oxidative stress (Broekemeier et al.,; Imberti et al., ), anoxia (Pastorino et al., ), or treatment with ATP (Zoeteweij et al., ); and in cardiomyocytes (Duchen et al., ) and isolated hearts (Griffiths and Halestrap, ) exposed to ischemia followed by reperfusion. The exponential increase in experimental papers dealing with the PT as an effector mechanism of cell death, however, only followed the demonstration that in the course of apoptosis cytochrome c is released into the cytosol (Liu et al., ) together with apoptosis-inducing factor (Susin et al., ) and a set of other proteins involved in the effector phase of apoptosis (Du et al.,; Ekert et al.,; Hegde et al.,; Li et al., ).

The molecular basis of the PT is still the matter of conjectures (Siemen and Ziemer, ). The various models and working hypotheses proposed over the years had to cope with the lack of selectivity for the permeating species, the strict requirement for matrix Ca2+, which has recently been established also for yeast mitochondria (Yamada et al., ), the stimulation by oxidants, the existence of a vast number of “inducers” without common structural features, and of a more limited but still substantial number of inhibitors (Gunter and Pfeiffer, ).

Adenine nucleotide translocator, VDAC, and contact sites

Inhibition of mitochondrial swelling by adenine nucleotides has long been appreciated (Raaflaub,; Brenner-Holzach and Raaflaub, ), but the idea that the adenine nucleotide translocator (ANT) is causally involved in the PT probably originates from the finding that Ca2+-dependent membrane permeabilization is affected by the ANT inhibitors atractylate and bongkrekate, atractylate being a PT inducer and bongkrekate a PT inhibitor (Hunter and Haworth, ). While early studies concluded (correctly, as it turns out) that the PT is an inner membrane event, the outer membrane was called into the picture after the work of Brdiczka and coworkers on inner-outer membrane contact sites, i.e., specialized structures where the two membranes form close contacts mediated by protein–protein interactions (Kottke et al., ). The contact sites were proposed to facilitate channeling of adenine nucleotides to and from mitochondria, and to comprise hexokinase on the cytosolic surface and VDAC within the outer membrane, creatine kinase and nucleoside diphosphate kinase (in tissues that express these proteins), and ANT in the inner membrane (Adams et al.,; Bucheler et al., ). The connection with the PTP was made in 1996, when the same laboratory found that hexokinase-enriched fractions formed channels with the conductance expected of the PTP, and conferred permeability properties to liposomes that could be inhibited by N-methylVal-4-cyclosporin (Beutner et al., ). Unlike the case of MMC, however, currents were inhibited rather than induced by atractylate; the active fractions were not enriched in VDAC or ANT; and the preparation contained a very large number of proteins (Beutner et al., ) making assignment of the channel activity to a specific species quite problematic. The same hexokinase-enriched fractions were used to study the interactions with proteins of the Bcl-2 family (Marzo et al., ). The hexokinase/VDAC/ANT model of the PTP was extended to include outer membrane TSPO [formerly known as peripheral benzodiazepine (Bz) receptor] and Bcl-2 family members (Zamzami and Kroemer, ). No further progress was made in the purification of the component(s) mediating channel activity and membrane permeabilization, yet this model became widely accepted as the “structure” of the PTP.

What did we learn from genetic inactivation of putative PTP components

Conclusive evidence that the ANT is not essential for PTP formation comes from analysis of mitochondria lacking all ANT isoforms, which revealed that a Ca2+-dependent PT took place (Kokoszka et al., ). The PT could be inhibited by CsA and triggered by thiol oxidants, demonstrating that the ANT is neither the obligatory binding partner of CyPD nor the site of action of oxidants (Kokoszka et al., ) as suggested earlier (Costantini et al., ). In addition, hepatocytes prepared from control and ANT-deficient livers showed identical responses to activation of receptor-mediated apoptotic pathways initiated by TNFα and Fas (Kokoszka et al., ). It has been argued that a low, undetectable level of ANT expression could explain the PT observed in ANT-null mitochondria (Halestrap, ). I believe that this possibility is quite remote because the PTP of mitochondria lacking ANT was insensitive to opening by atractylate and to closure by ADP (Kokoszka et al., ). As noted elsewhere (Bernardi et al., ) it is very difficult to envisage how any ANT molecules present in mutant mitochondria would promote a CsA-sensitive PT and yet not respond to atractylate and ADP.

A detailed comparison of the PT in mitochondria from wild-type and Vdac1−/− mice demonstrated that VDAC1 is fully dispensable for PTP opening and regulation (Krauskopf et al., ). Furthermore, the PT of mitochondria prepared from Vdac3−/− and Vdac1−/−Vdac3−/− mice, or from fibroblasts lacking all three VDAC isoforms, was identical to that of strain-matched wild-type mitochondria (Baines et al., ). Taken together, these results clearly indicate that VDACs are not components of the PTP although, as discussed later in the review, the outer membrane appears to participate in PTP regulation (Sinha Roy et al.,; Šileikyte et al., ).

TSPO is an 18 kDa highly hydrophobic protein, involved in cholesterol and protophorphyrin transport, which is located in the outer mitochondrial membrane (Batarseh and Papadopoulos, ). It was initially identified as a binding site for Bz in tissues that lack GABA receptors (Anholt et al.,, ). TSPO binds with nM affinity a variety of ligands, notably the Bz Ro5-4864 and the isoquinoline carboxamide PK11195 (Verma et al., ) as well as protoporphyrin IX, a potent inducer of the PTP (Pastorino et al., ). Treatment with TSPO ligands does affect the channel activity of the MMC–PTP in the proper concentration range (Kinnally et al., ) but TSPO is not the only mitochondrial protein binding these compounds, which have been shown to interact with, and inhibit, the FOF1 ATP synthase (Cleary et al., ). The latter finding acquires a particular meaning in the light of our recent demonstration that FOF1 ATP synthase dimers form channels indistinguishable from the PTP that can be activated by Bz-423 (Giorgio et al., ). Perhaps not surprisingly then, the PTP of mitochondria from mice where expression of TSPO had been conditionally inactivated could still be sensitized to Ca2+ by TSPO ligands, and had general features indistinguishable from those of mitochondria isolated from mice with wild-type genotype (Šileikytė, Forte et al., unpublished observations).

In summary, what we learned from gene inactivation studies is that none of the channel-forming proteins suggested to take part in PTP formation is necessary for its occurrence.

Alternative models for PTP formation

The Halestrap laboratory has proposed a new model for the PTP that envisions the formation of a pore by the Pi carrier (Leung et al., ). PTP formation would be favored by Ca2+ and CyPD binding, and the open probability would be increased by formation of a heterodimer with the ANT (Leung and Halestrap, ). This model still needs to be tested by reconstitution and by genetic means, but it should be noted that patch-clamp experiments with the functionally active mitochondrial Pi carrier revealed an anion-selective channel function with a mean conductance as low as 40 pS (the typical conductance of the PTP is 1.0−1.3 nS, and the channel is not ion-selective). Furthermore, the current was decreased to 25 pS by both Ca2+ (which activates the PTP) and Mg2+ (which inhibits it). Finally, and at striking variance with the pore, channel activity was inhibited by Pi and unaffected by ADP (Herick et al., ). These features make the Pi carrier a very unlikely candidate as a PTP component.

A radically different model of the PTP has been proposed in which the pore does not form from a specific protein but rather from aggregation of misfolded integral membrane proteins damaged by oxidant and other stresses (Kowaltowski et al.,; He and Lemasters, ). In the hypothesis of He and Lemasters conductance through misfolded protein clusters would be normally blocked by chaperone-like proteins (including CyPD) and modulated by Ca2+ and CsA. Opening of “unregulated” pores would occur when protein clusters exceed available chaperones (He and Lemasters, ). This model fails to account for the absolute Ca2+ requirement of PTP, and its regulation by voltage (Bernardi, ), matrix pH (Nicolli et al., ), and adenine nucleotides, all effects that are not easy to reconcile with a permeability pathway created by a heterogeneous set of denatured proteins.

It should be mentioned that Ca2+-dependent, CsA-insensitive PT-like channel activities have been described that are formed or activated by 3-hydroxybutyrate/polyphosphate (Pavlov et al., ) and by fatty acids (Mironova et al.,; Sultan and Sokolove, ). The latter observation links to early work demonstrating that fatty acids are potent inducers of mitochondrial swelling (Lehninger and Remmert,; Wojtczak and Lehninger, ), which was later recognized to be due to PTP opening (Scorrano et al.,; Bernardi et al., ).

Cyclophilin D and FoF1 ATP synthase

CyPs are ubiquitous, conserved proteins possessing PPIase activity (Fischer et al.,; Takahashi et al., ) sharing a common domain of about 109 amino acids, the CyP-like domain (Wang and Heitman, ). In man 16 unique CyPs have been found, the prototype being cytosolic CyPA (Wang and Heitman, ). After binding CsA the PPIase activity is inhibited (Borel et al., ) and the CsA/CyPA complex binds to and inhibits the cytosolic phosphatase calcineurin (Liu et al., ), causing immunosuppression (Clipstone and Crabtree,; Walsh et al., ).

CyPD is the mitochondrial CyP isoform in mammals (Connern and Halestrap,; Nicolli et al.,; Woodfield et al., ), see Giorgio et al. for a review. Much on its role in PTP regulation has been learned by genetic ablation of the Ppif gene (which encodes for CyPD). CyPD is the mitochondrial receptor for CsA and modulates the PTP but is not a structural pore component (Baines et al.,; Basso et al.,; Nakagawa et al.,; Schinzel et al., ). As discussed elsewhere (Bernardi et al., ), the effect of CsA on the PTP is best described as “desensitization” in the sense that the PTP becomes more resistant to opening by Ca2+ and Pi. It should be stressed that pore opening readily takes place for Ca2+-Pi loads that are about twice those required in wild-type mitochondria. This indicates that Ppif−/− (CyPD-null) mitochondria are not null for the PTP. This consideration is important for the interpretation of results obtained with CsA because (similarly to the absence of CyPD) CsA can desensitize but not block the PTP; thus, lack of sensitivity to CsA does not necessarily mean that the PTP is not involved in the event being studied. Furthermore, expression of CyPD is modulated, e.g., by muscle denervation (Csukly et al., ), and only CyPD-expressing mitochondria respond to CsA (Li et al., ). No endogenous ligands of CyPD mimicking the effects of CsA are known, but other PTP (de)sensitizers might act by favoring CyPD association or dissociation, as documented for acidic pH and increasing ionic strength (Nicolli et al., ). Furthermore, CyPD phosphorylation (Rasola et al., ), acetylation (Shulga and Pastorino, ), and nitrosylation (Kohr et al.,; Nguyen et al., ) affect the propensity of the PTP to open (Rasola and Bernardi, ). Not surprisingly CyPD may interact with many proteins including Hsp90 and its related molecule TRAP-1 (Kang et al., ); Bcl-2 (Eliseev et al., ); ERK-2/GSK-3 (Rasola et al., ); possibly p53 (Vaseva et al., ), but see (Karch and Molkentin, ); and the FOF1 ATP synthase (Giorgio et al., ). The latter interaction turned out to be the key for identification of the PTP.

The FOF1 ATP synthase (or complex V) is the rotary enzyme that synthesizes the vast majority of ATP in respiring cells (Rees et al., ). It is formed by the catalytic F1, the membrane-bound proton-translocating FO, and the lateral stalk linking F1 and FO (Strauss et al.,; Thomas et al.,; Rees et al.,; Baker et al.,; Davies et al., ) (Figure 1). The lateral stalk acts as a stator preventing the α3β3 subcomplex of F1 from rotating with subunits γ, δ, and ε and the ring of FO-subunits c (Rees et al., ). The FOF1 ATP synthase complex associates to form dimers, which are considered to be the “building blocks” of long rows of oligomers that promote cristae formation and may optimize the enzyme's catalytic performance (Campanella et al.,; Strauss et al.,; Thomas et al.,; Rees et al.,; Baker et al.,; Davies et al., ). The angle formed by the dimers seems to display a large variability, and dimers are believed to represent the physiological unit of complex V in the inner membrane (Thomas et al., ).

We found that CyPD binds the lateral stalk of complex V in an apparent ratio of 1:1:1:1 with the OSCP, b and d subunits (Giorgio et al., ). CyPD binding requires Pi and results in partial inhibition of ATP synthase activity, while CsA displaces CyPD resulting in enzyme reactivation (Giorgio et al., ). The stimulatory effect of CsA on enzyme catalysis is lost in Ppif−/− mitochondria, proving that it is mediated by CyPD, while assembly of the ATP synthase is not affected by CyPD ablation (Giorgio et al., ). In spite of the striking analogies with PTP regulation (Pi dependence, CsA sensitivity) whether the interactions of CyPD with complex V are relevant for the PT remained unknown until very recently.

Dimers of FoF1 ATP synthase form channels indistinguishable from the MMC–PTP

We have defined the binding site of CyPD on ATP synthase to the OSCP subunit, and shown that the interaction is electrostatic in nature. Modeling of surface potentials and isopotential curves suggested that CyPD interacts with OSCP in a region overlapping with helices 3 and 4, and this turned out to be a key insight (Giorgio et al., ). Indeed, this is also the binding site of Bz-423, a well-characterized inhibitor of the FOF1 ATP synthase (Johnson et al.,; Stelzer et al., ). If the CyPD interactions are important for the PT, it was logical to expect that Bz-423 should act as a PTP inducer, and this was the case. Bz-423 sensitized the PTP to Ca2+, and the inducing effect was blunted by Pi at concentrations that increase CyPD binding to OSCP (Giorgio et al., ). Consistent with an involvement of complex V in PTP formation, decreased levels of OSCP did affect the Ca2+ dependence of the pore. Indeed, mitochondria took up Ca2+ normally when ATP was used as the energy source, but the threshold Ca2+ load required for PTP opening was halved, which is the first molecular evidence that OSCP affects the probability of pore opening. Consistent with a key role of the ATP synthase, the Ca2+ affinity of the PTP was also affected by enzyme catalysis in the sense that ATP-hydrolyzing mitochondria required twice the Ca2+ load of ATP-synthesizing organelles, an effect as large as that of CsA (Giorgio et al., ).

Direct evidence that the PTP forms from the FOF1 ATP synthase was obtained by incorporating dimers purified by blue native electrophoresis into azolectin bilayers, and by measuring the passage of currents after application of a voltage difference. Addition of Bz-423 in the presence of Ca2+ triggered opening of high-conductance channels that were blocked by Mg2+/ADP and by the ATP synthase inhibitor AMP-PNP (γ-imino ATP, a non hydrolyzable ATP analog). Monomers of ATP synthase were devoid of channel activity in spite of the same overall subunit composition as the dimers (Tomasetig et al.,; Giorgio et al., ). The characteristics of the reconstituted pore closely matched those of MMC–PTP (Petronilli et al.,; Szabó and Zoratti,; Szabó et al., ). Maximal chord conductance was between 1.0 and 1.3 nS in symmetrical KCl 150 mM, and various subconductance states were observed. Like the MMC of Ppif−/− mitochondria (De Marchi et al., ), and in keeping with the lack of CyPD in the preparations, the channel was insensitive to CsA. Ca2+ and Pi, which sensitize the PTP even in the absence of CyPD, sufficed to induce PTP currents when dimers were prepared in the presence of 10 mM Pi. Channel openings could not be elicited by atractyloside and, once elicited by Bz-423, were still observed in the presence of bongkrekic acid. These findings are consistent with the absence of ANT in the preparations, which also totally lacked VDAC (Giorgio et al., ).

Bz-423 was characterized as an apoptosis-inducing agent acting through mitochondria (Blatt et al., ) and OSCP was identified as its target through the unbiased screening of a human phage display library (Johnson et al., ). The selectivity of action of Bz-423 on OSCP, its ability to trigger channel activity of ATP synthase dimers, and the lack of activity of monomer preparations strongly argues against the possibility that the currents observed by Giorgio et al. are due to unidentified contaminating proteins. The PTP-inducing effect of Bz-423 and CyPD (which both act through OSCP on top of the lateral stalk in the matrix) must be indirect, as it affects the permeability properties of the inner membrane. We assume that the PTP forms at the membrane interface between two adjacent FO sectors, which could also accommodate the effects of fatty acids (Lehninger and Remmert,; Wojtczak and Lehninger,; Bernardi et al., ). Matrix Ca2+ has an essential permissive role in PTP formation, and we have suggested that accessibility of Ca2+ to the metal binding sites of the catalytic F1 sector is influenced by OSCP. This subunit could indeed affect the affinity of the metal binding sites of ATP synthase and thus determine the ease with which matrix Ca2+ can replace Mg2+ causing PTP opening. Our working hypothesis is that OSCP as such is a “negative” modulator, whose effect can be counteracted by binding of the “positive” effector CyPD (which indeed increases the apparent Ca2+ affinity of the PTP). Removal of OSCP, or CyPD binding to OSCP, would induce similar conformational effects leading to increased probability of PTP opening, a working hypothesis that awaits experimental verification.

A cartoon with the hypothetical events leading to PTP formation from complex V dimers is presented in Figure 2. In the “coupled” condition the dimers bind Mg2+-ADP/ATP, and the concentration of free Ca2+ (and Pi, not shown in the Figure) is not high enough for the PT to occur (panel A). Binding of CyPD, which is favored by Pi (Giorgio et al., ), would cause a conformational change affecting accessibility of the metal binding sites. This in turn would decrease the matrix Ca2+ load necessary to trigger the PT (panels B,D). The transition would essentially depend on replacement of Mg2+ with Ca2+, which in the absence of CyPD binding would require higher matrix Ca2+ loads (panel C). Accessibility of the metal binding site (and probability of occurrence of the PT at a given Ca2+ load) would be increased by thiol oxidation and counteracted by thiol reduction. Ion and solute permeation would then occur at the interface between the c rings (panels C,D). The PT can be fully reverted by Ca2+ chelation with EGTA (Petronilli et al., ), which would restore Mg2+ binding and allow the dimer to recover the coupled structure.

Role of outer membrane

It can no longer be questioned that the PT is an inner membrane event since (1) complex V dimers suffice to induce MMC activity and (2) Ca2+-dependent PT occurs in mitoplasts, i.e., mitochondria stripped of the outer membrane (Šileikyte et al., ). These findings should not be taken to imply that the outer membrane does not play a role in PTP modulation, which is in fact supported by a large number of studies. An early indication was provided by Lê-Quôc and Lê-Quôc, who showed that induction of the PTP by substituted maleimides requires the outer membrane (Lê-Quôc and Lê-Quôc, ). We have fully confirmed this “sensitizing” role of the outer membrane by an independent approach, i.e., irradiation of mitochondria with visible light after treatment with hematoporphyrin, a strategy that allows production of singlet oxygen leading to PTP inactivation or reactivation depending on the light dose (Ricchelli et al., ). Low light doses inactivate the PTP through degradation of hystidyl residues that prevent cysteine oxidation on the matrix side (Salet et al., ), while higher light doses activate the PTP through cysteine oxidation at the outer membrane (Moreno et al.,; Petronilli et al., ). Mitoplasts are completely resistant to PTP induction by high light doses (Šileikyte et al., ) proving that the outer membrane can favor PTP opening through a still unidentified mechanism (Ricchelli et al., ).

Bcl-2 family proteins, which are generally believed to locate to the outer membrane, affect the PTP (Forte and Bernardi, ). According to several studies Bcl-2 increases resistance to the PT (Susin et al.,; Decaudin et al., ) while Bax and/or Bad activated by tBid favor PTP opening (Pastorino et al.,,; Scorrano et al.,; Sinha Roy et al., ). Although CsA did not prevent cytochrome c release in one study where tBid was used, it is not known whether the cells expressed CyPD and were therefore sensitive to CsA inhibition (Garcia-Perez et al., ), an issue that may explain discrepancies with earlier studies (Scorrano et al.,; Tafani et al., ). Occurrence of a PT is instead opposed by outer membrane binding of hexokinase II (Pastorino et al.,,; Chiara et al., ), which counteracts the inducing effects of Bax (Pastorino et al., ). It must be mentioned that Bcl-2 family proteins also interact with other targets. Indeed, tBid initiates a CsA-sensitive process of cristae remodeling that increases cytochrome c availability in the intermembrane space, which is consistent with a PT-dependent facilitation of cytochrome c release even when the outer membrane is intact (Scorrano et al.,, ); and Bax inhibits the mitochondrial inner membrane potassium channel Kv1.3 (Szabó et al., ), a proapoptotic effect that critically depends on Bax residue K128 and is abrogated by a K128E mutation, while an E158K mutation in antiapoptotic Bcl-xL (position 158 of Bcl-xL corresponds to position 128 of Bax) turns Bcl-xL into a proapoptotic protein (Szabó et al., ).

The detailed mechanisms through which the outer membrane affects formation of the PTP remain to be addressed. I would like to stress that the vast majority of complex V is located in long rows of oligomers deep inside mitochondrial cristae (Strauss et al.,; Davies et al.,, ) where direct physical interaction with the outer membrane is obviously not possible. Thus, either the PTP forms in the small population of dimers facing the intermembrane space, where direct contact with the outer membrane can occur; or the effect is exerted by controlling the diffusion of PTP-regulating metabolites and ions including Ca2+ itself (Madesh and Hajnoczky,; Rapizzi et al., ) in a process that would be greatly favored by cristae remodeling (Scorrano et al., ).

The PTP as a calcium release channel

We have recently reviewed the hypothesis (Bernardi and Petronilli,; Ichas et al., ) that the PTP may open transiently (Hüser et al.,; Hüser and Blatter,; Petronilli et al.,, ) to operate as a mitochondrial Ca2+ release channel under physiological conditions (Bernardi and von Stockum, ). The basis for this hypothesis goes back to 1992, when Altschuld et al. reported that CsA significantly increases net Ca2+ uptake and decreases Ca2+ efflux in isolated cardiomyocytes, as measured by radiolabeled 45Ca2+, through a demonstrably mitochondrial effect that has no impact on cell morphology or viability (Altschuld et al., ). Three recent publications based on Ppif−/− cells and mice support this hypothesis (Elrod et al.,; Barsukova et al.,; Parone et al., ).

An age-related phenotype was discovered in the hearts of Ppif−/− mice, which dysplayed decreased contractile reserve and increased shortening and relaxation times, with longer decay of cytosolic Ca2+ transients (Elrod et al., ). Direct measurement of total mitochondrial Ca2+ content of Ppif−/− hearts showed a 2.6-fold increase, which was matched by larger Ca2+ transients in mitochondria of myocytes treated with CsA. Under continuous pacing PTP desensitization with CsA decreased the rise time in Ca2+ accumulation and prolonged the recovery time after pacing, findings that are entirely consistent with the PTP acting as a Ca2+ release channel to prevent Ca2+ overload (Elrod et al., ). Consistent with this idea, cytosolic [Ca2+] increases induced by either ATP or depolarizing concentrations of KCl gave comparable transient increases of mitochondrial [Ca2+] in adult cortical neurons from wild type and Ppif−/− mice; while application of the two stimuli together resulted in much higher levels of mitochondrial [Ca2+] in the Ppif−/− neurons, suggesting that the threshold for PTP activation had been reached in the wild type but not in the CyPD-null mitochondria in situ. These data indicate that the regulatory role of CyPD (and thus PTP opening) in Ca2+ homeostasis may be essential only for relatively large mitochondrial Ca2+ loads (Barsukova et al., ). Mice expressing amyotrophic lateral sclerosis-linked mutants of superoxide dismutase (SOD) 1 develop a motor neuron disease with many pathological hallmarks seen in patients (Gurney et al., ). Spinal cord mitochondria from these mice display decreased Ca2+ retention capacity long before onset of motor weakness and neuronal death (Damiano et al., ), and this was corrected by genetic elimination of the Ppif−/− gene (Parone et al., ). Improved mitochondrial Ca2+ buffering was matched by improved mitochondrial ATP synthesis and reduced swelling, attenuation of glial activation, reduction of misfolded SOD1 aggregates in the spinal cord, and significant suppression of motor neuron death throughout disease, although survival was unfortunately not improved (Parone et al., ).

Transient PTP openings appear also to be at the basis of “superoxide flashes” observed with mitochondrially targeted, circularly permuted yellow fluorescent protein (mt-cpYFP) in a variety of cell types (Wang et al.,,; Fang et al., ). There is an ongoing debate on whether the flashes are in fact partially or totally due to changes of matrix pH (Schwarzlander et al.,, ), although it is fair to say that the measured matrix alkalinization appears to be way too small to account for the fluorescence changes of mt-cpYFP (Wei-Lapierre et al., ).

The recent finding that Drosophila mitochondria possess a PTP-related but CsA-insensitive Ca2+ release channel selective for Ca2+ and H+ (von Stockum et al., ) provides a nice model system, and perhaps the missing link between the PTP of yeast and mammals (Azzolin et al., ). I am confident that it will be now possible to address the potential role of the PTP as a Ca2+ release channel through inhibition of the “pore function” of ATP synthase dimers through appropriate drugs and through genetic manipulation.

Complex I

The PTP has the remarkable feature of being modulated by electron flow through complex I (Fontaine et al., ), which may in part be linked to the fact that NADH oxidation favors PTP opening (Costantini et al., ). A specific role of complex I, however, is suggested by the striking discovery that in mammalian mitochondria rotenone can be an effective inhibitor of the pore (Chauvin et al.,; Li et al., ). Inhibition of the PT by rotenone is maximal in mitochondria from tissues that express low levels of CyPD, where CsA has little inhibitory effect; while inhibition by CsA is maximal in mitochondria from tissues with high levels of expression of CyPD, where rotenone does not affect the PTP. Finally, tissues with mitochondria expressing intermediate levels of CyPD are sensitive to both rotenone and CsA, with additive effects of the two inhibitors (Li et al., ). Intriguingly, the inhibitory effect of rotenone is potentiated by Pi, which is reminiscent of the Pi requirement for inhibition by CsA (Basso et al., ). The concentrations of rotenone required for PT inhibition matched quite precisely those required to inhibit respiration, and a similar PT-inhibiting effect was seen with metformin, which partially inhibits complex I as well (El Mir et al.,; Guigas et al., ). Since rotenone and metformin do not share common structural features, it appears likely that modulation of the PTP by inhibition of complex I is indirect, and possibly mediated by inhibition of complex I-derived reactive oxygen species (Batandier et al., ). An indirect effect is also suggested by the observations (1) that a Ca2+-dependent (albeit CsA-insensitive) PT can occur in mitochondria from yeast strains that do not possess an energy-conserving complex I (Jung et al.,; Yamada et al.,; Uribe-Carvajal et al., ); (2) that complex I purified by blue native electrophoresis did not form Ca2+-activated channels in lipid bilayers under conditions that instead promote MMC opening after incorporation of complex V (Giorgio et al., ); and (3) that complex I does not colocalize with ATP synthase oligomers (Davies et al., ).

Quinones

The regulatory effects of quinones on the PTP has been discovered in our laboratory in 1998 (Fontaine et al.,,) and thoroughly characterized by Fontaine and Coworkers (Walter et al.,,; Devun et al., ). Ub0 (i.e., ubiquinone without a side chain) is the most potent inhibitor of the PTP; the dose-dependence displays a bell-shaped curve, however, a feature that is also typical of other inhibitory quinones like decylubiquinone (Fontaine et al.,,; Fontaine and Bernardi,; Walter et al., ). PTP-inducing quinones include idebenone (Walter et al., ) while idebenol (the reduced form) is no longer effective, suggesting that the effect on the PTP is related to oxidation-reduction events (Giorgio et al., ). The structure–function relationship of quinones for PTP inhibition/activation has not been solved, and further complexity arises from the fact that the same quinone can have opposite effects depending on the cell type (Devun et al., ). It appears possible that, like substituted maleimides, Ub0 affects PTP formation in part at least through its ability to form adducts with SH groups, which is not shared by short-chain quinones. ROS-forming ability of the latter does not always correlate with their PTP-inducing features (Devun et al., ) and the general mechanism of action of quinones on the PT remains to be solved.

Conclusions and perspectives

The findings that (1) dimers of the ATP synthase treated with Ca2+ generate currents indistinguishable from the MMC–PTP; (2) channel openings are favored by Bz-423 and thiol oxidants; (3) channel openings are inhibited by adenine nucleotides and Mg2+; and (4) monomers lack any channel activity, all represent strong indications that the PTP forms from a specific, Ca2+-dependent conformation of the dimers. The FOF1 ATP synthase readily accommodates key pathophysiological effectors of the PT since Ca2+, Mg2+, adenine nucleotides, and Pi bind the catalytic core at F1; and the membrane potential and matrix pH, which are key PTP modulators (Bernardi et al., ), are also key regulators of the ATP synthase. On the other hand, several regulators of the PTP (specifically, rotenone and quinones) are not easily accounted for by the dimer hypothesis, and their mechanism of action will need further studies. However, I believe that our findings provide a novel and stimulating working hypothesis that should help address outstanding issues including species-specific features of the PTP of rats (Ricchelli et al.,; Zulian et al., ), yeast (Jung et al.,; Manon et al.,; Yamada et al.,; Uribe-Carvajal et al., ), and Drosophila melanogaster (von Stockum et al., ); and the mystery of Artemia franciscana, an anoxia and salt-tolerant brine shrimp whose mitochondria are refractory to PTP opening (Menze et al.,, ). Together our results suggest a dual function for complex V, ATP synthesis and PTP formation. The key enzyme of life appears therefore to be also the molecular switch that signals the presence of fully depolarized, dysfunctional mitochondria to promote cell death (Rasola and Bernardi, ) and/or mitophagy (Youle and Narendra, ).

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References 199

  1. 1.

    Adams V. Bosch W. Schlegel J. Wallimann T. Brdiczka D. (1989 ). Further characterization of contact sites from mitochondria of different tissues: topology of peripheral kinases. Biochim. Biophys. Acta 981, 213–225

    Not in our library10.1016/0005-2736(89)90031-x

  2. 2.

    Al Nasser I. Crompton M. (1986 ). The reversible Ca2+-induced permeabilization of rat liver mitochondria. Biochem. J. 239, 19–29

    Not in our library10.1042/bj2390019

  3. 3.

    Altschuld R. A. Hohl C. M. Castillo L. C. Garleb A. A. Starling R. C. Brierley G. P. (1992 ). Cyclosporin inhibits mitochondrial calcium efflux in isolated adult rat ventricular cardiomyocytes. Am. J. Physiol. 262, H1699–H1704

    Not in our library10.1152/ajpheart.1992.262.6.h1699

  4. 4.

    Anholt R. R. De Souza E. B. Oster-Granite M. L. Snyder S. H. (1985 ). Peripheral-type benzodiazepine receptors: autoradiographic localization in whole-body sections of neonatal rats. J. Pharmacol. Exp. Ther. 233, 517–526

    Not in our library

  5. 5.

    Anholt R. R. Pedersen P. L. De Souza E. B. Snyder S. H. (1986 ). The peripheral-type benzodiazepine receptor. Localization to the mitochondrial outer membrane. J. Biol. Chem. 261, 576–583

    Not in our library

  6. 6.

    Azzi A. Azzone G. F. (1965 ). Swelling and shrinkage phenomena in liver mitochondria. I. Large amplitude swelling induced by inorganic phosphate and by ATP. Biochim. Biophys. Acta 105, 253–264

    Not in our library10.1016/s0926-6593(65)80150-3

  7. 7.

    Azzolin L. von Stockum S. Basso E. Petronilli V. Forte M. A. Bernardi P. (2010 ). The mitochondrial permeability transition from yeast to mammals. FEBS Lett. 584, 2504–2509

    Not in our library10.1016/j.febslet.2010.04.023

  8. 8.

    Azzone G. F. Azzi A. (1965 ). Volume changes in liver mitochondria. Proc. Natl. Acad. Sci. U.S.A. 53, 1084–1089

    Not in our library10.1073/pnas.53.5.1084

  9. 9.

    Baines C. P. Kaiser R. A. Purcell N. H. Blair N. S. Osinska H. Hambleton M. A. (2005 ). Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662

    Not in our library10.1038/nature03434

  10. 10.

    Baines C. P. Kaiser R. A. Sheiko T. Craigen W. J. Molkentin J. D. (2007 ). Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat. Cell Biol. 9, 550–555

    Not in our library10.1038/ncb1575

  11. 11.

    Baker L. A. Watt I. N. Runswick M. J. Walker J. E. Rubinstein J. L. (2012 ). Arrangement of subunits in intact mammalian mitochondrial ATP synthase determined by cryo-EM. Proc. Natl. Acad. Sci. U.S.A. 109, 11675–11680

    Not in our library10.1073/pnas.1204935109

  12. 12.

    Barsukova A. Komarov A. Hajnoczky G. Bernardi P. Bourdette D. Forte M. (2011 ). Activation of the mitochondrial permeability transition pore modulates Ca2+ responses to physiological stimuli in adult neurons. Eur. J. Neurosci. 33, 831–842

    Not in our library10.1111/j.1460-9568.2010.07576.x

  13. 13.

    Basso E. Fante L. Fowlkes J. Petronilli V. Forte M. A. Bernardi P. (2005 ). Properties of the permeability transition pore in mitochondria devoid of Cyclophilin, D. J. Biol. Chem. 280, 18558–18561

    Not in our library10.1074/jbc.c500089200

  14. 14.

    Basso E. Petronilli V. Forte M. A. Bernardi P. (2008 ). Phosphate is essential for inhibition of the mitochondrial permeability transition pore by cyclosporin A and by cyclophilin D ablation. J. Biol. Chem. 283, 26307–26311

    Not in our library10.1074/jbc.c800132200

  15. 15.

    Batandier C. Leverve X. Fontaine E. (2004 ). Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex, I. J. Biol. Chem. 279, 17197–17204

    Not in our library10.1074/jbc.m310329200

  16. 16.

    Batarseh A. Papadopoulos V. (2010 ). Regulation of translocator protein 18kDa (TSPO) expression in health and disease states. Mol. Cell. Endocrinol. 327, 1–12

    Not in our library10.1016/j.mce.2010.06.013

  17. 17.

    Beatrice M. C. Palmer J. W. Pfeiffer D. R. (1980 ). The relationship between mitochondrial membrane permeability, membrane potential, and the retention of Ca2+ by mitochondria. J. Biol. Chem. 255, 8663–8671

    Not in our library

  18. 18.

    Bernardi P. (1992 ). Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by the proton electrochemical gradient. Evidence that the pore can be opened by membrane depolarization. J. Biol. Chem. 267, 8834–8839

    Not in our library

  19. 19.

    Bernardi P. (1999 ). Mitochondrial transport of cations: channels, exchangers and permeability transition. Physiol. Rev. 79, 1127–1155

    Not in our library10.1152/physrev.1999.79.4.1127

  20. 20.

    Bernardi P. Krauskopf A. Basso E. Petronilli V. Blachly-Dyson E. Di Lisa F. (2006 ). The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J. 273, 2077–2099

    Not in our library10.1111/j.1742-4658.2006.05213.x

  21. 21.

    Bernardi P. Penzo D. Wojtczak L. (2002 ). Mitochondrial energy dissipation by fatty acids. Mechanisms and implications for cell death. Vitam. Horm. 65, 97–126

    Not in our library10.1016/s0083-6729(02)65061-7

  22. 22.

    Bernardi P. Petronilli V. (1996 ). The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr. 28, 131–138

    Not in our library10.1007/bf02110643

  23. 23.

    Bernardi P. Pietrobon D. (1982 ). On the nature of Pi-induced, Mg2+-prevented Ca2+ release in rat liver mitochondria. FEBS Lett. 139, 9–12

    Not in our library10.1016/0014-5793(82)80475-4

  24. 24.

    Bernardi P. Vassanelli S. Veronese P. Colonna R. Szabo I. Zoratti M. (1992 ). Modulation of the mitochondrial permeability transition pore. Effect of protons and divalent cations. J. Biol. Chem. 267, 2934–2939

    Not in our library

  25. 25.

    Bernardi P. von Stockum S. (2012 ). The permeability transition pore as a Ca2+ release channel: new answers to an old question. Cell Calcium 52, 22–27

    Not in our library10.1016/j.ceca.2012.03.004

  26. 26.

    Beutner G. Rück A. Riede B. Welte W. Brdiczka D. (1996 ). Complexes between kinases, mitochondrial porin and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett. 396, 189–195

    Not in our library10.1016/0014-5793(96)01092-7

  27. 27.

    Blatt N. B. Bednarski J. J. Warner R. E. Leonetti F. Johnson K. M. Boitano A. (2002 ). Benzodiazepine-induced superoxide signals B cell apoptosis: mechanistic insight and potential therapeutic utility. J. Clin. Invest. 110, 1123–1132

    Not in our library10.1172/jci16029

  28. 28.

    Borel J. F. Feurer C. Magnee C. Stahelin H. (1977 ). Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32, 1017–1025

    Not in our library

  29. 29.

    Brenner-Holzach O. Raaflaub J. (1954 ). Die korrelation zwischen der schwellung isolierter mitochondrien und dem abbau intramitochondrialen adenosinnucleotide (ATP, ADP, AMP, CoA). Helv. Physiol. Pharmacol. Acta 12, 242–252

    Not in our library

  30. 30.

    Broekemeier K. M. Carpenter Deyo L. Reed D. J. Pfeiffer D. R. (1992 ). Cyclosporin A protects hepatocytes subjected to high Ca2+ and oxidative stress. FEBS Lett. 304, 192–194

    Not in our library10.1016/0014-5793(92)80616-o

  31. 31.

    Broekemeier K. M. Dempsey M. E. Pfeiffer D. R. (1989 ). Cyclosporin A is a potent inhibitor of the inner membrane permeability transition in liver mitochondria. J. Biol. Chem. 264, 7826–7830

    Not in our library

  32. 32.

    Bucheler K. Adams V. Brdiczka D. (1991 ). Localization of the ATP/ADP translocator in the inner membrane and regulation of contact sites between mitochondrial envelope membranes by ADP. A study on freeze-fractured isolated liver mitochondria. Biochim. Biophys. Acta 1056, 233–242

    Not in our library10.1016/s0005-2728(05)80054-4

  33. 33.

    Campanella M. Casswell E. Chong S. Farah Z. Wieckowski M. R. Abramov A. Y. (2008 ). Regulation of mitochondrial structure and function by the F1Fo-ATPase inhibitor protein, IF1. Cell Metab. 8, 13–25

    Not in our library10.1016/j.cmet.2008.06.001

  34. 34.

    Chappell J. B. Crofts A. R. (1965 ). Calcium ion accumulation and volume changes of isolated liver mitochondria. Calcium ion-induced swelling. Biochem. J. 95, 378–386

    Not in our library10.1042/bj0950378

  35. 35.

    Chauvin C. De Oliveira F. Ronot X. Mousseau M. Leverve X. Fontaine E. (2001 ). Rotenone inhibits the mitochondrial permeability transition-induced cell death in U937 and KB cells. J. Biol. Chem. 276, 41394–41398

    Not in our library10.1074/jbc.m106417200

  36. 36.
    Hexokinase II Detachment from Mitochondria Triggers Apoptosis through the Permeability Transition Pore Independent of Voltage-Dependent Anion Channels · 2008
    No notice
  37. 37.

    Cleary J. Johnson K. M. Opipari A. W. Jr. Glick G. D. (2007 ). Inhibition of the mitochondrial F1F0-ATPase by ligands of the peripheral benzodiazepine receptor. Bioorg. Med. Chem. Lett. 17, 1667–1670

    Not in our library10.1016/j.bmcl.2006.12.102

  38. 38.

    Clipstone N. A. Crabtree G. R. (1992 ). Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation. Nature 357, 695–697

    Not in our library10.1038/357695a0

  39. 39.

    Coelho J. L. Vercesi A. E. (1980 ). Retention of Ca2+ by rat liver and rat heart mitochondria: effect of phosphate, Mg2+, and NAD(P) redox state. Arch. Biochem. Biophys. 204, 141–147

    Not in our library10.1016/0003-9861(80)90016-8

  40. 40.

    Connern C. P. Halestrap A. P. (1992 ). Purification and N-terminal sequencing of peptidyl-prolyl cis-trans-isomerase from rat liver mitochondrial matrix reveals the existence of a distinct mitochondrial cyclophilin. Biochem. J. 284, 381–385

    Not in our library10.1042/bj2840381

  41. 41.

    Connern C. P. Halestrap A. P. (1994 ). Recruitment of mitochondrial cyclophilin to the mitochondrial inner membrane under conditions of oxidative stress that enhance the opening of a calcium-sensitive non-specific channel. Biochem. J. 302, 321–324

    Not in our library10.1042/bj3020321

  42. 42.

    Costantini P. Chernyak B. V. Petronilli V. Bernardi P. (1996 ). Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 271, 6746–6751

    Not in our library10.1074/jbc.271.12.6746

  43. 43.

    Costantini P. Colonna R. Bernardi P. (1998 ). Induction of the mitochondrial permeability transition by N-ethylmaleimide depends on secondary oxidation of critical thiol groups. Potentiation by copper-ortho-phenanthroline without dimerization of the adenine nucleotide translocase. Biochim. Biophys. Acta 1365, 385–392

    Not in our library10.1016/s0005-2728(98)00090-5

  44. 44.

    Crofts A. R. Chappell J. B. (1965 ). Calcium ion accumulation and volume changes of isolated rat liver mitochondria. Reversal of calcium ion-induced swelling. Biochem. J. 95, 387–392

    Not in our library10.1042/bj0950387

  45. 45.

    Crompton M. Costi A. (1988 ). Kinetic evidence for a heart mitochondrial pore activated by Ca2+, inorganic phosphate and oxidative stress. A potential mechanism for mitochondrial dysfunction during cellular Ca2+ overload. Eur. J. Biochem. 178, 489–501

    Not in our library10.1111/j.1432-1033.1988.tb14475.x

  46. 46.

    Crompton M. Ellinger H. Costi A. (1988 ). Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem. J. 255, 357–360

    Not in our library

  47. 47.

    Csukly K. Ascah A. Matas J. Gardiner P. F. Fontaine E. Burelle Y. (2006 ). Muscle denervation promotes opening of the permeability transition pore and increases the expression of cyclophilin D. J. Physiol. 574, 319–327

    Not in our library10.1113/jphysiol.2006.109702

  48. 48.

    Damiano M. Starkov A. A. Petri S. Kipiani K. Kiaei M. Mattiazzi M. (2006 ). Neural mitochondrial Ca2+ capacity impairment precedes the onset of motor symptoms in G93A Cu/Zn-superoxide dismutase mutant mice. J. Neurochem. 96, 1349–1361

    Not in our library10.1111/j.1471-4159.2006.03619.x

  49. 49.

    Davidson A. M. Halestrap A. P. (1990 ). Partial inhibition by cyclosporin A of the swelling of liver mitochondria in vivo and in vitro induced by sub-micromolar [Ca2+], but not by butyrate. Evidence for two distinct swelling mechanisms. Biochem. J. 268, 147–152

    Not in our library10.1042/bj2680147

  50. 50.

    Davies K. M. Anselmi C. Wittig I. Faraldo-Gomez J. D. Kühlbrandt W. (2012 ). Structure of the yeast F1Fo-ATP synthase dimer and its role in shaping the mitochondrial cristae. Proc. Natl. Acad. Sci. U.S.A. 109, 13602–13607

    Not in our library10.1073/pnas.1204593109

  51. 51.

    Davies K. M. Strauss M. Daum B. Kief J. H. Osiewacz H. D. Rycovska A. (2011 ). Macromolecular organization of ATP synthase and complex I in whole mitochondria. Proc. Natl. Acad. Sci. U.S.A. 108, 14121–14126

    Not in our library10.1073/pnas.1103621108

  52. 52.

    Decaudin D. Geley S. Hirsch T. Castedo M. Marchetti P. Macho A. (1997 ). Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57, 62–67

    Not in our library

  53. 53.

    De Marchi U. Basso E. Szabó I. Zoratti M. (2006 ). Electrophysiological characterization of the Cyclophilin D-deleted mitochondrial permeability transition pore. Mol. Membr. Biol. 23, 521–530

    Not in our library10.1080/09687860600907644

  54. 54.

    Devun F. Walter L. Belliere J. Cottet-Rousselle C. Leverve X. Fontaine E. (2010 ). Ubiquinone analogs: a mitochondrial permeability transition pore-dependent pathway to selective cell death. PLoS ONE 5:e11792

    Not in our library10.1371/journal.pone.0011792

  55. 55.

    Du C. Fang M. Li Y. Li L. Wang X. (2000 ). Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 102, 33–42

    Not in our library10.1016/s0092-8674(00)00008-8

  56. 56.

    Duchen M. R. McGuinness O. Brown L. A. Crompton M. (1993 ). On the involvement of a cyclosporin A sensitive mitochondrial pore in myocardial reperfusion injury. Cardiovasc. Res. 27, 1790–1794

    Not in our library10.1093/cvr/27.10.1790

  57. 57.

    Ekert P. G. Silke J. Connolly L. M. Reid G. E. Moritz R. L. Vaux D. L. (2000 ). Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 102, 43–53

    Not in our library10.1016/s0092-8674(00)00009-x

  58. 58.

    Eliseev R. A. Malecki J. Lester T. Zhang Y. Humphrey J. Gunter T. E. (2009 ). Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect. J. Biol. Chem. 284, 9692–9699

    Not in our library10.1074/jbc.m808750200

  59. 59.

    El Mir M. Y. Nogueira V. Fontaine E. Averet N. Rigoulet M. Leverve X. (2000 ). Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain complex I. J. Biol. Chem. 275, 223–228

    Not in our library10.1074/jbc.275.1.223

  60. 60.

    Elrod J. W. Wong R. Mishra S. Vagnozzi R. J. Sakthievel B. Goonasekera S. A. (2010 ). Cyclophilin D controls mitochondrial pore-dependent Ca2+ exchange, metabolic flexibility, and propensity for heart failure in mice. J. Clin. Invest. 120, 3680–3687

    Not in our library10.1172/jci43171

  61. 61.

    Fang H. Chen M. Ding Y. Shang W. Xu J. Zhang X. (2011 ). Imaging superoxide flash and metabolism-coupled mitochondrial permeability transition in living animals. Cell Res. 21, 1295–1304

    Not in our library10.1038/cr.2011.81

  62. 62.

    Fischer G. Wittmann-Liebold B. Lang K. Kiefhaber T. Schmid F. X. (1989 ). Cyclophilin and peptidyl-prolyl cis-trans isomerase are probably identical proteins. Nature 337, 476–478

    Not in our library10.1038/337476a0

  63. 63.

    Fontaine E. Bernardi P. (1999 ). Progress on the mitochondrial permeability transition pore: regulation by complex I and ubiquinone analogs. J. Bioenerg. Biomembr. 31, 335–345

    Not in our library10.1023/a:1005475802350

  64. 64.

    Fontaine E. Eriksson O. Ichas F. Bernardi P. (1998a ). Regulation of the permeability transition pore in skeletal muscle mitochondria. Modulation by electron flow through the respiratory chain complex I. J. Biol. Chem. 273, 12662–12668

    Not in our library10.1074/jbc.273.20.12662

  65. 65.

    Fontaine E. Ichas F. Bernardi P. (1998b ). A ubiquinone-binding site regulates the mitochondrial permeability transition pore. J. Biol. Chem. 273, 25734–25740

    Not in our library10.1074/jbc.273.40.25734

  66. 66.

    Forte M. Bernardi P. (2006 ). The permeability transition and BCL-2 family proteins in apoptosis: co-conspirators or independent agents? Cell Death Differ. 13, 1287–1290

    Not in our library10.1038/sj.cdd.4401957

  67. 67.

    Fournier N. Ducet G. Crevat A. (1987 ). Action of cyclosporine on mitochondrial calcium fluxes. J. Bioenerg. Biomembr. 19, 297–303

    Not in our library10.1007/bf00762419

  68. 68.

    Garcia-Perez C. Roy S. S. Naghdi S. Lin X. Davies E. Hajnoczky G. (2012 ). Bid-induced mitochondrial membrane permeabilization waves propagated by local reactive oxygen species (ROS) signaling. Proc. Natl. Acad. Sci. U.S.A. 109, 4497–4502

    Not in our library10.1073/pnas.1118244109

  69. 69.

    Giorgio V. Bisetto E. Soriano M. E. Dabbeni-Sala F. Basso E. Petronilli V. (2009 ). Cyclophilin D modulates mitochondrial FOF1-ATP synthase by interacting with the lateral stalk of the complex. J. Biol. Chem. 284, 33982–33988

    Not in our library10.1074/jbc.m109.020115

  70. 70.
    The effects of idebenone on mitochondrial bioenergetics · 2012
    No notice
  71. 71.

    Giorgio V. Soriano M. E. Basso E. Bisetto E. Lippe G. Forte M. A. (2010 ). Cyclophilin D in mitochondrial pathophysiology. Biochim. Biophys. Acta 1797, 1113–1118

    Not in our library10.1016/j.bbabio.2009.12.006

  72. 72.

    Giorgio V. von Stockum S. Antoniel M. Fabbro A. Fogolari F. Forte M. (2013 ). Dimers of mitochondrial ATP synthase form the permeability transition pore. Proc. Natl. Acad. Sci. U.S.A. 110, 5887–5892

    Not in our library10.1073/pnas.1217823110

  73. 73.

    Griffiths E. J. Halestrap A. P. (1995 ). Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion. Biochem. J. 307, 93–98

    Not in our library10.1042/bj3070093

  74. 74.

    Guigas B. Detaille D. Chauvin C. Batandier C. De Oliveira F. Fontaine E. (2004 ). Metformin inhibits mitochondrial permeability transition and cell death: a pharmacological in vitro study. Biochem. J. 382, 877–884

    Not in our library10.1042/bj20040885

  75. 75.

    Gunter T. E. Pfeiffer D. R. (1990 ). Mechanisms by which mitochondria transport calcium. Am. J. Physiol. 258, C755–C786

    Not in our library10.1152/ajpcell.1990.258.5.c755

  76. 76.

    Gurney M. E. Pu H. Chiu A. Y. Dal Canto M. C. Polchow C. Y. Alexander D. D. (1994 ). Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264, 1772–1775

    Not in our library10.1126/science.8209258

  77. 77.

    Halestrap A. P. (2004 ). Mitochondrial permeability: dual role for the ADP/ATP translocator? Nature 430, 1 p following 983.

    Not in our library10.1038/nature02816

  78. 78.

    Haworth R. A. Hunter D. R. (1979 ). The Ca2+-induced membrane transition of rat liver mitochondria. II. Nature of the Ca2+ trigger site. Arch. Biochem. Biophys. 195, 460–467

    Not in our library10.1016/0003-9861(79)90372-2

  79. 79.

    He L. Lemasters J. J. (2002 ). Regulated and unregulated mitochondrial permeability transition pores: a new paradigm of pore structure and function? FEBS Lett. 512, 1–7

    Not in our library10.1016/s0014-5793(01)03314-2

  80. 80.

    Hegde R. Srinivasula S. M. Zhang Z. Wassell R. Mukattash R. Cilenti L. (2001 ). Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J. Biol. Chem. 277, 432–438

    Not in our library10.1074/jbc.m109721200

  81. 81.

    Herick K. Krämer R. Lühring H. (1997 ). Patch clamp investigation into the phosphate carrier from Saccharomyces cerevisiae mitochondria. Biochim. Biophys. Acta 1321, 207–220

    Not in our library10.1016/s0005-2728(97)00050-9

  82. 82.

    Hunter D. R. Haworth R. A. (1979a ). The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. Arch. Biochem. Biophys. 195, 453–459

    Not in our library10.1016/0003-9861(79)90371-0

  83. 83.

    Hunter D. R. Haworth R. A. (1979b ). The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. Arch. Biochem. Biophys. 195, 468–477

    Not in our library10.1016/0003-9861(79)90373-4

  84. 84.

    Hunter D. R. Haworth R. A. Southard J. H. (1976 ). Relationship between configuration, function, and permeability in calcium-treated mitochondria. J. Biol. Chem. 251, 5069–5077

    Not in our library

  85. 85.

    Hunter F. E. Jr. Ford L. (1955 ). Inactivation of oxidative and phosphorylative systems in mitochondria by preincubation with phosphate and other ions. J. Biol. Chem. 216, 357–369

    Not in our library

  86. 86.

    Hüser J. Blatter L. A. (1999 ). Fluctuations in mitochondrial membrane potential caused by repetitive gating of the permeability transition pore. Biochem. J. 343, 311–317

    Not in our library

  87. 87.

    Hüser J. Rechenmacher C. E. Blatter L. A. (1998 ). Imaging the permeability pore transition in single mitochondria. Biophys. J. 74, 2129–2137

    Not in our library10.1016/s0006-3495(98)77920-2

  88. 88.

    Ichas F. Jouaville L. S. Mazat J. P. (1997 ). Mitochondria are excitable organelles capable of generating and conveying electrical and calcium signals. Cell 89, 1145–1153

    Not in our library10.1016/s0092-8674(00)80301-3

  89. 89.

    Imberti R. Nieminen A. L. Herman B. Lemasters J. J. (1992 ). Synergism of cyclosporin A and phospholipase inhibitors in protection against lethal injury to rat hepatocytes from oxidant chemicals. Res. Commun. Chem. Pathol. Pharmacol. 78, 27–38

    Not in our library

  90. 90.

    Johnson K. M. Chen X. Boitano A. Swenson L. Opipari A. W. Jr. Glick G. D. (2005 ). Identification and validation of the mitochondrial F1F0-ATPase as the molecular target of the immunomodulatory benzodiazepine Bz-423. Chem. Biol. 12, 485–496

    Not in our library10.1016/j.chembiol.2005.02.012

  91. 91.

    Jung D. W. Bradshaw P. C. Pfeiffer D. R. (1997 ). Properties of a cyclosporin-insensitive permeability transition pore in yeast mitochondria. J. Biol. Chem. 272, 21104–21112

    Not in our library10.1074/jbc.272.34.21104

  92. 92.

    Kang B. H. Plescia J. Dohi T. Rosa J. Doxsey S. J. Altieri D. C. (2007 ). Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network. Cell 131, 257–270

    Not in our library10.1016/j.cell.2007.08.028

  93. 93.

    Karch J. Molkentin J. D. (2012 ). Is p53 the long-sought molecular trigger for cyclophilin D-regulated mitochondrial permeability transition pore formation and necrosis? Circ. Res. 111, 1258–1260

    Not in our library10.1161/circresaha.112.280990

  94. 94.

    Kinnally K. W. Campo M. L. Tedeschi H. (1989 ). Mitochondrial channel activity studied by patch-clamping mitoplasts. J. Bioenerg. Biomembr. 21, 497–506

    Not in our library10.1007/bf00762521

  95. 95.

    Kinnally K. W. Zorov D. B. Antonenko Y. N. Snyder S. H. McEnery M. W. Tedeschi H. (1993 ). Mitochondrial benzodiazepine receptor linked to inner membrane ion channels by nanomolar actions of ligands. Proc. Natl. Acad. Sci. U.S.A. 90, 1374–1378

    Not in our library10.1073/pnas.90.4.1374

  96. 96.

    Kohr M. J. Aponte A. M. Sun J. Wang G. Murphy E. Gucek M. (2011 ). Characterization of potential S-nitrosylation sites in the myocardium. Am. J. Physiol. Heart Circ. Physiol. 300, H1327–H1335

    Not in our library10.1152/ajpheart.00997.2010

  97. 97.

    Kokoszka J. E. Waymire K. G. Levy S. E. Sligh J. E. Cai J. Jones D. P. (2004 ). The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. Nature 427, 461–465

    Not in our library10.1038/nature02229

  98. 98.

    Kottke M. Adam V. Riesinger I. Bremm G. Bosch W. Brdiczka D. (1988 ). Mitochondrial boundary membrane contact sites in brain: points of hexokinase and creatine kinase location, and control of Ca2+ transport. Biochim. Biophys. Acta 935, 87–102

    Not in our library10.1016/0005-2728(88)90111-9

  99. 99.

    Kowaltowski A. J. Castilho R. F. Vercesi A. E. (2001 ). Mitochondrial permeability transition and oxidative stress. FEBS Lett. 495, 12–15

    Not in our library10.1016/s0014-5793(01)02316-x

  100. 100.

    Krauskopf A. Eriksson O. Craigen W. J. Forte M. A. Bernardi P. (2006 ). Properties of the permeability transition in VDAC1(-/-) mitochondria. Biochim. Biophys. Acta 1757, 590–595

    Not in our library10.1016/j.bbabio.2006.02.007

  101. 101.

    Lehninger A. L. (1959 ). Reversal of various types of mitochondrial swelling by adenosine triphosphate. J. Biol. Chem. 234, 2465–2471

    Not in our library

  102. 102.

    Lehninger A. L. Remmert L. F. (1959 ). An endogenous uncoupling and swelling agent in liver mitochondria and its enzymic function. J. Biol. Chem. 234, 2459–2464

    Not in our library

  103. 103.

    Lê-Quôc K. Lê-Quôc D. (1982 ). Control of the mitochondrial inner membrane permeability by sulfhydryl groups. Arch. Biochem. Biophys. 216, 639–651

    Not in our library10.1016/0003-9861(82)90254-5

  104. 104.

    Lê-Quôc K. Lê-Quôc D. (1985 ). Crucial role of sulfhydryl groups in the mitochondrial inner membrane structure. J. Biol. Chem. 260, 7422–7428

    Not in our library

  105. 105.

    Leung A. W. Halestrap A. P. (2008 ). Recent progress in elucidating the molecular mechanism of the mitochondrial permeability transition pore. Biochim. Biophys. Acta 1777, 946–952

    Not in our library10.1016/j.bbabio.2008.03.009

  106. 106.

    Leung A. W. Varanyuwatana P. Halestrap A. P. (2008 ). The mitochondrial phosphate carrier interacts with cyclophilin D and may play a key role in the permeability transition. J. Biol. Chem. 283, 26312–26323

    Not in our library10.1074/jbc.m805235200

  107. 107.

    Li B. Chauvin C. De P. D. De O. F. Gharib A. Vial G. (2012 ). Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D. Biochim. Biophys. Acta 1817, 1628–1634

    Not in our library10.1016/j.bbabio.2012.05.011

  108. 108.

    Li L. Y. Luo X. Wang X. (2001 ). Endonuclease G is an apoptotic DNase when released from mitochondria. Nature 412, 95–99

    Not in our library10.1038/35083620

  109. 109.

    Liu J. Farmer J. D. J. Lane W. S. Friedman J. Weissman I. Schreiber S. L. (1991 ). Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66, 807–815

    Not in our library10.1016/0092-8674(91)90124-h

  110. 110.

    Liu X. Kim C. N. Yang J. Jemmerson R. Wang X. (1996 ). Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 86, 147–157

    Not in our library10.1016/s0092-8674(00)80085-9

  111. 111.

    Madesh M. Hajnoczky G. (2001 ). VDAC-dependent permeabilization of the outer mitochondrial membrane by superoxide induces rapid and massive cytochrome c release. J. Cell Biol. 155, 1003–1015

    Not in our library10.1083/jcb.200105057

  112. 112.

    Manon S. Roucou X. Guerin M. Rigoulet M. Guerin B. (1998 ). Characterization of the yeast mitochondria unselective channel: a counterpart to the mammalian permeability transition pore? J. Bioenerg. Biomembr. 30, 419–429

    Not in our library10.1023/a:1020533928491

  113. 113.

    Marzo I. Brenner C. Zamzami N. Susin S. A. Beutner G. Brdiczka D. (1998 ). The permeability transition pore complex: a target for apoptosis regulation by caspases and bcl-2-related proteins. J. Exp. Med. 187, 1261–1271

    Not in our library10.1084/jem.187.8.1261

  114. 114.

    Menze M. A. Fortner G. Nag S. Hand S. C. (2010 ). Mechanisms of apoptosis in Crustacea: what conditions induce versus suppress cell death? Apoptosis 15, 293–312

    Not in our library10.1007/s10495-009-0443-6

  115. 115.

    Menze M. A. Hutchinson K. Laborde S. M. Hand S. C. (2005 ). Mitochondrial permeability transition in the crustacean Artemia franciscana: absence of a calcium-regulated pore in the face of profound calcium storage. Am. J. Physiol. 289, R68–R76

    Not in our library10.1152/ajpregu.00844.2004

  116. 116.

    Mironova G. D. Gateau-Roesch O. Levrat C. Gritsenko E. Pavlov E. Lazareva A. V. (2001 ). Palmitic and stearic acids bind Ca2+ with high affinity and form nonspecific channels in black-lipid membranes. Possible relation to Ca2+-activated mitochondrial pores. J. Bioenerg. Biomembr. 33, 319–331

    Not in our library10.1023/a:1010659323937

  117. 117.

    Mitchell P. (1961 ). Coupling of phosphorylation to electron and hydrogen transfer by a chemio-osmotic type of mechanism. Nature 191, 144–148

    Not in our library10.1038/191144a0

  118. 118.

    Mitchell P. (2011 ). Chemiosmotic coupling in oxidative and photosynthetic phosphorylation. 1966. Biochim. Biophys. Acta 1807, 1507–1538

    Not in our library10.1016/j.bbabio.2011.09.018

  119. 119.

    Moreno G. Poussin K. Ricchelli F. Salet C. (2001 ). The effects of singlet oxygen produced by photodynamic action on the mitochondrial permeability transition differ in accordance with the localization of the sensitizer. Arch. Biochem. Biophys. 386, 243–250

    Not in our library10.1006/abbi.2000.2200

  120. 120.

    Nakagawa T. Shimizu S. Watanabe T. Yamaguchi O. Otsu K. Yamagata H. (2005 ). Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652–658

    Not in our library10.1038/nature03317

  121. 121.

    Nguyen T. T. Stevens M. V. Kohr M. Steenbergen C. Sack M. N. Murphy E. (2011 ). Cysteine 203 of cyclophilin D is critical for cyclophilin D activation of the mitochondrial permeability transition pore. J. Biol. Chem. 286, 40184–40192

    Not in our library10.1074/jbc.m111.243469

  122. 122.

    Nicolli A. Basso E. Petronilli V. Wenger R. M. Bernardi P. (1996 ). Interactions of cyclophilin with the mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem. 271, 2185–2192

    Not in our library10.1074/jbc.271.4.2185

  123. 123.

    Nicolli A. Petronilli V. Bernardi P. (1993 ). Modulation of the mitochondrial cyclosporin A-sensitive permeability transition pore by matrix pH. Evidence that the pore open-closed probability is regulated by reversible histidine protonation. Biochemistry 32, 4461–4465

    Not in our library10.1021/bi00067a039

  124. 124.

    Parone P. A. Da C. S. Han J. S. McAlonis-Downes M. Vetto A. P. Lee S. K. (2013 ). Enhancing mitochondrial calcium buffering capacity reduces aggregation of misfolded SOD1 and motor neuron cell death without extending survival in mouse models of inherited amyotrophic lateral sclerosis. J. Neurosci. 33, 4657–4671

    Not in our library10.1523/jneurosci.1119-12.2013

  125. 125.

    Pastorino J. G. Chen S. T. Tafani M. Snyder J. W. Farber J. L. (1998 ). The overexpression of Bax produces cell death upon induction of the mitochondrial permeability transition. J. Biol. Chem. 273, 7770–7775

    Not in our library10.1074/jbc.273.13.7770

  126. 126.

    Pastorino J. G. Hoek J. B. Shulga N. (2005 ). Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 65, 10545–10554

    Not in our library10.1158/0008-5472.can-05-1925

  127. 127.

    Pastorino J. G. Shulga N. Hoek J. B. (2002 ). Mitochondrial binding of hexokinase II inhibits bax-induced cytochrome c release and apoptosis. J. Biol. Chem. 277, 7610–7618

    Not in our library10.1074/jbc.m109950200

  128. 128.

    Pastorino J. G. Simbula G. Gilfor E. Hoek J. B. Farber J. L. (1994 ). Protoporphyrin, IX, an endogenous ligand of the peripheral benzodiazepine receptor, potentiates induction of the mitochondrial permeability transition and the killing of cultured hepatocytes by rotenone. J. Biol. Chem. 269, 31041–31046

    Not in our library

  129. 129.

    Pastorino J. G. Snyder J. W. Serroni A. Hoek J. B. Farber J. L. (1993 ). Cyclosporin and carnitine prevent the anoxic death of cultured hepatocytes by inhibiting the mitochondrial permeability transition. J. Biol. Chem. 268, 13791–13798

    Not in our library

  130. 130.

    Pastorino J. G. Tafani M. Rothman R. J. Marcineviciute A. Hoek J. B. Farber J. L. (1999 ). Functional consequences of the sustained or transient activation by Bax of the mitochondrial permeability transition pore. J. Biol. Chem. 274, 31734–31739

    Not in our library10.1074/jbc.274.44.31734

  131. 131.

    Pavlov E. Zakharian E. Bladen C. Diao C. T. Grimbly C. Reusch R. N. (2005 ). A large, voltage-dependent channel, isolated from mitochondria by water-free chloroform extraction. Biophys. J. 88, 2614–2625

    Not in our library10.1529/biophysj.104.057281

  132. 132.

    Petronilli V. Miotto G. Canton M. Brini M. Colonna R. Bernardi P. (1999 ). Transient and long-lasting openings of the mitochondrial permeability transition pore can be monitored directly in intact cells by changes in mitochondrial calcein fluorescence. Biophys. J. 76, 725–734

    Not in our library10.1016/s0006-3495(99)77239-5

  133. 133.

    Petronilli V. Nicolli A. Costantini P. Colonna R. Bernardi P. (1994 ). Regulation of the permeability transition pore, a voltage-dependent mitochondrial channel inhibited by cyclosporin A. Biochim. Biophys. Acta 1187, 255–259

    Not in our library10.1016/0005-2728(94)90122-8

  134. 134.

    Petronilli V. Penzo D. Scorrano L. Bernardi P. Di Lisa F. (2001 ). The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ. J. Biol. Chem. 276, 12030–12034

    Not in our library10.1074/jbc.m010604200

  135. 135.

    Petronilli V. Šileikyte J. Zulian A. Dabbeni-Sala F. Jori G. Gobbo S. (2009 ). Switch from inhibition to activation of the mitochondrial permeability transition during hematoporphyrin-mediated photooxidative stress. Unmasking pore-regulating external thiols. Biochim. Biophys. Acta 1787, 897–904

    Not in our library10.1016/j.bbabio.2009.03.014

  136. 136.

    Petronilli V. Szabó I. Zoratti M. (1989 ). The inner mitochondrial membrane contains ion-conducting channels similar to those found in bacteria. FEBS Lett. 259, 137–143

    Not in our library10.1016/0014-5793(89)81513-3

  137. 137.

    Pfeiffer D. R. Kuo T. H. Tchen T. T. (1976 ). Some effects of Ca2+, Mg2+, and Mn2+ on the ultrastructure, light-scattering properties, and malic enzyme activity of adrenal cortex mitochondria. Arch. Biochem. Biophys. 176, 556–563

    Not in our library10.1016/0003-9861(76)90199-5

  138. 138.

    Pfeiffer D. R. Tchen T. T. (1973 ). The role of Ca2+ in control of malic enzyme activity in bovine adrenal cortex mitochondria. Biochem. Biophys. Res. Commun. 50, 807–813

    Not in our library10.1016/0006-291x(73)91316-8

  139. 139.

    Pfeiffer D. R. Tchen T. T. (1975 ). The activation of adrenal cortex mitochondrial malic enzyme by Ca2+ and Mg2+. Biochemistry 14, 89–96

    Not in our library10.1021/bi00672a015

  140. 140.

    Raaflaub J. (1953a ). Die schwellung isolierter leberzell mitochondrien und ihre physikalisch beeinfluβarkeit. Helv. Physiol. Pharmacol. Acta 11, 142–156

    Not in our library

  141. 141.

    Raaflaub J. (1953b ). Über den wirkungsmechanismus von adenosintriphosphat (ATP) als cofaktor isolierter mitochondrien. Helv. Physiol. Pharmacol. Acta 11, 157–165

    Not in our library

  142. 142.

    Rapizzi E. Pinton P. Szabadkai G. Wieckowski M. R. Vandecasteele G. Baird G. (2002 ). Recombinant expression of the voltage-dependent anion channel enhances the transfer of Ca2+ microdomains to mitochondria. J. Cell Biol. 159, 613–624

    Not in our library10.1083/jcb.200205091

  143. 143.

    Rasola A. Bernardi P. (2007 ). The mitochondrial permeability transition pore and its involvement in cell death and in disease pathogenesis. Apoptosis 12, 815–833

    Not in our library10.1007/s10495-007-0723-y

  144. 144.

    Rasola A. Bernardi P. (2011 ). Mitochondrial permeability transition in Ca2+-dependent apoptosis and necrosis. Cell Calcium 50, 222–233

    Not in our library10.1016/j.ceca.2011.04.007

  145. 145.

    Rasola A. Sciacovelli M. Chiara F. Pantic B. Brusilow W. S. Bernardi P. (2010 ). Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition. Proc. Natl. Acad. Sci. U.S.A. 107, 726–731

    Not in our library10.1073/pnas.0912742107

  146. 146.

    Rees D. M. Leslie A. G. Walker J. E. (2009 ). The structure of the membrane extrinsic region of bovine ATP synthase. Proc. Natl. Acad. Sci. U.S.A. 106, 21597–21601

    Not in our library10.1073/pnas.0910365106

  147. 147.

    Ricchelli F. Dabbeni-Sala F. Petronilli V. Bernardi P. Hopkins B. Bova S. (2005 ). Species-specific modulation of the mitochondrial permeability transition by norbormide. Biochim. Biophys. Acta 1708, 178–186

    Not in our library10.1016/j.bbabio.2005.03.002

  148. 148.

    Ricchelli F. Šileikyte J. Bernardi P. (2011 ). Shedding light on the mitochondrial permeability transition. Biochim. Biophys. Acta 1807, 482–490

    Not in our library10.1016/j.bbabio.2011.02.012

  149. 149.

    Riley W. W. Jr. Pfeiffer D. R. (1985 ). Relationships between Ca2+ release, Ca2+ cycling, and Ca2+- mediated permeability changes in mitochondria. J. Biol. Chem. 260, 12416–12425

    Not in our library

  150. 150.

    Salet C. Moreno G. Ricchelli F. Bernardi P. (1997 ). Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore. J. Biol. Chem. 272, 21938–21943

    Not in our library10.1074/jbc.272.35.21938

  151. 151.

    Schinzel A. C. Takeuchi O. Huang Z. Fisher J. K. Zhou Z. Rubens J. (2005 ). Cyclophilin D is a component of mitochondrial permeability transition and mediates neuronal cell death after focal cerebral ischemia. Proc. Natl. Acad. Sci. U.S.A. 102, 12005–12010

    Not in our library10.1073/pnas.0505294102

  152. 152.

    Schwarzlander M. Logan D. C. Fricker M. D. Sweetlove L. J. (2011 ). The circularly permuted yellow fluorescent protein cpYFP that has been used as a superoxide probe is highly responsive to pH but not superoxide in mitochondria: implications for the existence of superoxide ‘flashes’. Biochem. J. 437, 381–387

    Not in our library10.1042/bj20110883

  153. 153.

    Schwarzlander M. Murphy M. P. Duchen M. R. Logan D. C. Fricker M. D. Halestrap A. P. (2012 ). Mitochondrial ‘flashes’: a radical concept repHined. Trends Cell Biol. 22, 503–508

    Not in our library10.1016/j.tcb.2012.07.007

  154. 154.

    Scorrano L. Ashiya M. Buttle K. Weiler S. Oakes S. A. Mannella C. A. (2002 ). A distinct pathway remodels mitochondrial cristae and mobilizes cytochrome c during apoptosis. Dev. Cell 2, 55–67

    Not in our library10.1016/s1534-5807(01)00116-2

  155. 155.

    Scorrano L. Oakes S. A. Opferman J. T. Cheng E. H. Sorcinelli M. D. Pozzan T. (2003 ). BAX and BAK regulation of endoplasmic reticulum Ca2+: a control point for apoptosis. Science 300, 135

    Not in our library10.1126/science.1081208

  156. 156.

    Scorrano L. Penzo D. Petronilli V. Pagano F. Bernardi P. (2001 ). Arachidonic acid causes cell death through the mitochondrial permeability transition. Implications for tumor necrosis factor-α apoptotic signaling. J. Biol. Chem. 276, 12035–12040

    Not in our library10.1074/jbc.m010603200

  157. 157.

    Shulga N. Pastorino J. G. (2010 ). Ethanol sensitizes mitochondria to the permeability transition by inhibiting deacetylation of cyclophilin-D mediated by sirtuin-3. J. Cell Sci. 123, 4117–4127

    Not in our library10.1242/jcs.073502

  158. 158.

    Siemen D. Ziemer M. (2013 ). What is the nature of the mitochondrial permeability transition pore and what is it not? IUBMB Life 65, 255–262

    Not in our library10.1002/iub.1130

  159. 159.

    Šileikyte J. Petronilli V. Zulian A. Dabbeni-Sala F. Tognon G. Nikolov P. (2011 ). Regulation of the inner membrane mitochondrial permeability transition by the outer membrane translocator protein (peripheral benzodiazepine receptor). J. Biol. Chem. 286, 1046–1053

    Not in our library10.1074/jbc.m110.172486

  160. 160.

    Siliprandi D. Siliprandi N. Toninello A. (1983 ). On the relationship between calcium and phosphate transport, transmembrane potential and acetoacetate-induced oxidation of pyridine nucleotides in rat liver mitochondria. Eur. J. Biochem. 130, 173–175

    Not in our library10.1111/j.1432-1033.1983.tb07133.x

  161. 161.

    Sinha Roy S. Madesh M. Davies E. Antonsson B. Danial N. Hajnoczky G. (2009 ). Bad targets the permeability transition pore independent of Bax or Bak to switch between Ca2+-dependent cell survival and death. Mol. Cell 33, 377–388

    Not in our library10.1016/j.molcel.2009.01.018

  162. 162.

    Sokolove P. M. Shinaberry R. G. (1988 ). Na+-independent release of Ca2+ from rat heart mitochondria. Induction by adriamycin aglycone. Biochem. Pharmacol. 37, 803–812

    Not in our library10.1016/0006-2952(88)90165-7

  163. 163.

    Sorgato M. C. Keller B. U. Stühmer W. (1987 ). Patch-clamping of the inner mitochondrial membrane reveals a voltage-dependent ion channel. Nature 330, 498–500

    Not in our library10.1038/330498a0

  164. 164.

    Stelzer A. C. Frazee R. W. Van Huis C. Cleary J. Opipari A. W. Jr. Glick G. D. (2010 ). NMR studies of an immunomodulatory benzodiazepine binding to its molecular target on the mitochondrial F1F0-ATPase. Biopolymers 93, 85–92

    Not in our library10.1002/bip.21306

  165. 165.

    Strauss M. Hofhaus G. Schroder R. R. Kühlbrandt W. (2008 ). Dimer ribbons of ATP synthase shape the inner mitochondrial membrane. EMBO J. 27, 1154–1160

    Not in our library10.1038/emboj.2008.35

  166. 166.

    Sultan A. Sokolove P. M. (2001 ). Free fatty acid effects on mitochondrial permeability: an overview. Arch. Biochem. Biophys. 386, 52–61

    Not in our library10.1006/abbi.2000.2195

  167. 167.

    Susin S. A. Zamzami N. Castedo M. Hirsch T. Marchetti P. Macho A. (1996 ). Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184, 1331–1341

    Not in our library10.1084/jem.184.4.1331

  168. 168.

    Szabó I. Bernardi P. Zoratti M. (1992 ). Modulation of the mitochondrial megachannel by divalent cations and protons. J. Biol. Chem. 267, 2940–2946

    Not in our library

  169. 169.

    Szabó I. Bock J. Grassme H. Soddemann M. Wilker B. Lang F. (2008 ). Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 105, 14861–14866

    Not in our library10.1073/pnas.0804236105

  170. 170.

    Szabó I. Soddemann M. Leanza L. Zoratti M. Gulbins E. (2011 ). Single-point mutations of a lysine residue change function of Bax and Bcl-xL expressed in Bax- and Bak-less mouse embryonic fibroblasts: novel insights into the molecular mechanisms of Bax-induced apoptosis. Cell Death Differ. 18, 427–438

    Not in our library10.1038/cdd.2010.112

  171. 171.

    Szabó I. Zoratti M. (1991 ). The giant channel of the inner mitochondrial membrane is inhibited by cyclosporin A. J. Biol. Chem. 266, 3376–3379

    Not in our library

  172. 172.

    Szabó I. Zoratti M. (1992 ). The mitochondrial megachannel is the permeability transition pore. J. Bioenerg. Biomembr. 24, 111–117

    Not in our library10.1007/bf00769537

  173. 173.

    Tafani M. Karpinich N. O. Hurster K. A. Pastorino J. G. Schneider T. Russo M. A. (2002 ). Cytochrome c release upon Fas receptor activation depends on translocation of full-length bid and the induction of the mitochondrial permeability transition. J. Biol. Chem. 277, 10073–10082

    Not in our library10.1074/jbc.m111350200

  174. 174.

    Takahashi N. Hayano T. Suzuki M. (1989 ). Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin. Nature 337, 473–475

    Not in our library10.1038/337473a0

  175. 175.

    Tapley D. F. (1956 ). The effect of thyroxine and other substances on the swelling of isolated rat liver mitochondria. J. Biol. Chem. 222, 325–339

    Not in our library

  176. 176.

    Thomas D. Bron P. Weimann T. Dautant A. Giraud M. F. Paumard P. (2008 ). Supramolecular organization of the yeast F1Fo-ATP synthase. Biol. Cell 100, 591–601

    Not in our library10.1042/bc20080022

  177. 177.

    Tomasetig L. Di Pancrazio F. Harris D. A. Mavelli I. Lippe G. (2002 ). Dimerization of F0F1ATP synthase from bovine heart is independent from the binding of the inhibitor protein IF1. Biochim. Biophys. Acta 1556, 133–141

    Not in our library10.1016/s0005-2728(02)00344-4

  178. 178.

    Uribe-Carvajal S. Luévano-Martìnez L. A. Guerrero-Castillo S. Cabrera-Orefice A. Corona-de-la-Peña N. A. Gutiérrez-Aguilar M. (2011 ). Mitochondrial unselective channels throughout the eukaryotic domain. Mitochondrion 11, 382–390

    Not in our library10.1016/j.mito.2011.02.004

  179. 179.

    Vaseva A. V. Marchenko N. D. Ji K. Tsirka S. E. Holzmann S. Moll U. M. (2012 ). p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell 149, 1536–1548

    Not in our library10.1016/j.cell.2012.05.014

  180. 180.

    Vercesi A. E. (1984 ). Dissociation of NAD(P)+-stimulated mitochondrial Ca2+ efflux from swelling and membrane damage. Arch. Biochem. Biophys. 232, 86–91

    Not in our library10.1016/0003-9861(84)90523-x

  181. 181.

    Verma A. Nye J. S. Snyder S. H. (1987 ). Porphyrins are endogenous ligands for the mitochondrial (peripheral-type) benzodiazepine receptor. Proc. Natl. Acad. Sci. U.S.A. 84, 2256–2260

    Not in our library10.1073/pnas.84.8.2256

  182. 182.

    Vinogradov A. Scarpa A. Chance B. (1972 ). Calcium and pyridine nucleotide interaction in mitochondrial membranes. Arch. Biochem. Biophys. 152, 646–654

    Not in our library10.1016/0003-9861(72)90261-5

  183. 183.

    von Stockum S. Basso E. Petronilli V. Sabatelli P. Forte M. A. Bernardi P. (2011 ). Properties of Ca2+ transport in mitochondria of Drosophila melanogaster. J. Biol. Chem. 286, 41163–41170

    Not in our library10.1074/jbc.m111.268375

  184. 184.

    Walsh C. T. Zydowsky L. D. McKeon F. D. (1992 ). Cyclosporin, A, the cyclophilin class of peptidylprolyl isomerases, and blockade of T cell signal transduction. J. Biol. Chem. 267, 13115–13118

    Not in our library

  185. 185.

    Walter L. Miyoshi H. Leverve X. Bernardi P. Fontaine E. (2002 ). Regulation of the mitochondrial permeability transition pore by ubiquinone analogs. A progress report. Free Radic. Res. 36, 405–412

    Not in our library10.1080/10715760290021252

  186. 186.

    Walter L. Nogueira V. Leverve X. Bernardi P. Fontaine E. (2000 ). Three classes of ubiquinone analogs regulate the mitochondrial permeability transition pore through a common site. J. Biol. Chem. 275, 29521–29527

    Not in our library10.1074/jbc.m004128200

  187. 187.

    Wang J. Q. Chen Q. Wang X. Wang Q. C. Wang Y. Cheng H. P. (2013 ). Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. J. Biol. Chem. 288, 3070–3084

    Not in our library10.1074/jbc.m112.407726

  188. 188.

    Wang P. Heitman J. (2005 ). The cyclophilins. Genome Biol. 6, 226.1–226.6

    Not in our library10.1186/gb-2005-6-7-226

  189. 189.

    Wang W. Fang H. Groom L. Cheng A. Zhang W. Liu J. (2008 ). Superoxide flashes in single mitochondria. Cell 134, 279–290

    Not in our library10.1016/j.cell.2008.06.017

  190. 190.

    Wei-Lapierre L. Gong G. Gerstner B. J. Ducreux S. Yule D. I. Pouvreau S. (2013 ). Respective contribution of mitochondrial superoxide and pH to Mt-cpYFP flash activity. J. Biol. Chem. 288, 10567–10577

    Not in our library10.1074/jbc.m113.455709

  191. 191.

    Wojtczak L. Lehninger A. L. (1961 ). Formation and disappearance of an endogenous uncoupling factor during swelling and contraction of mitochondria. Biochim. Biophys. Acta 51, 442–456

    Not in our library10.1016/0006-3002(61)90600-x

  192. 192.

    Woodfield K. Y. Price N. T. Halestrap A. P. (1997 ). cDNA cloning of rat mitochondrial cyclophilin. Biochim. Biophys. Acta 1351, 27–30

    Not in our library10.1016/s0167-4781(97)00017-1

  193. 193.

    Yamada A. Yamamoto T. Yoshimura Y. Gouda S. Kawashima S. Yamazaki N. (2009 ). Ca2+-induced permeability transition can be observed even in yeast mitochondria under optimized experimental conditions. Biochim. Biophys. Acta 1787, 1486–1491

    Not in our library10.1016/j.bbabio.2009.07.001

  194. 194.

    Youle R. J. Narendra D. P. (2011 ). Mechanisms of mitophagy. Nat. Rev. Mol. Cell. Biol. 12, 9–14

    Not in our library10.1038/nrm3028

  195. 195.

    Zamzami N. Kroemer G. (2001 ). The mitochondrion in apoptosis: how Pandora's box opens. Nat. Rev. Mol. Cell. Biol. 2, 67–71

    Not in our library10.1038/35048073

  196. 196.

    Zborowski J. Wojtczak L. (1963 ). Induction of swelling of liver mitochondria by fatty acids of various chain length. Biochim. Biophys. Acta 70, 596–598

    Not in our library10.1016/0006-3002(63)90799-6

  197. 197.

    Zoeteweij J. P. van de Water B. de Bont H. J. Mulder G. J. Nagelkerke J. F. (1993 ). Calcium-induced cytotoxicity in hepatocytes after exposure to extracellular ATP is dependent on inorganic phosphate. Effects on mitochondrial calcium. J. Biol. Chem. 268, 3384–3388

    Not in our library

  198. 198.

    Zoratti M. Szabó I. De Marchi U. (2005 ). Mitochondrial permeability transitions: how many doors to the house? Biochim. Biophys. Acta 1706, 40–52

    Not in our library10.1016/j.bbabio.2004.10.006

  199. 199.

    Zulian A. Petronilli V. Bova S. Dabbeni-Sala F. Cargnelli G. Cavalli M. (2007 ). Assessing the molecular basis for rat-selective induction of the mitochondrial permeability transition by norbormide. Biochim. Biophys. Acta 1767, 980–988

    Not in our library10.1016/j.bbabio.2007.04.002

Cited by papers we hold 7

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.